Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of 6 weeks of treatment with
beclomethasone dipropionate (BDP) nasal aerosol versus placebo on HPA-axis function, as
assessed by 24-hour serum cortisol weighted mean, and to evaluate the safety and tolerability
of BDP nasal aerosol, in subjects 6 to 11 years of age with perennial allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries